PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for October 23, 2009 Add to my Yahoo! Subscribe to this News Feed Subscribe to this News Feed   
 

The Mulligan Law Firm Is Evaluating Potential Calaxo® Bone Screw Claims

Patients who underwent ACL knee surgery between March 2006 and November 2007 may have been implanted with the Calaxo Surgical Screw. There is a possibility of severe complications. Contact the Mulligan Law Firm at www.mulliganlaw.com for additional information about Calaxo® Surgical Screw Issues.

Dallas, TX (PRWEB) October 23, 2009 -- Severe complications are a possibility if you have been implanted with the Calaxo® Surgical Screw, and if this has happened, The Mulligan Law Firm would like to hear from you.

Manufactured by Smith & Nephew, the Calaxo screw (officially known as the Calaxo Osteoconductive Interference Screw) was approved by the FDA and first made available for use in the U.S. in March of 2006.

Developed to replace the metal screws in use at that time, the Calaxo screw is composed of bioabsorbable polymer and calcium carbonate. The metal screws required a follow-up operation to remove, but the Calaxo screw was designed to stay in the body and be absorbed over the 12 month period following surgery. The Calaxo screw tethered the ligament, and as it dissolved it was supposed to promote bone growth and increase the speed of healing.

In August of 2007, Smith & Nephew issued a voluntary recall of all lots of the Calaxo screw, in light of increasing reports of severe surgical side effects. According to the FDA, over 68,000 units were recalled in the U.S.

Calaxo Screw Side-Effects

The following Information on the recall and side-effects are from the Federal Food and Drug Administration (FDA) and its published papers about the Calaxo Screw.

The Calaxo bone screw first began to be used after FDA approval in 2006. Almost immediately, reports began to surface about possible severe side effects. In some cases, patients were developing soft-tissue swelling between two and 36 weeks after surgery.

The screws were breaking inside the body and causing severe knee pain, painful swelling, infection, and fluid buildup, requiring additional surgery.

Some cases require additional surgery involving debridement (removal of dead or infected tissue and bone) and removal of remaining screw fragments. In a few cases, surgeons have also replaced the fragmented polymer screw with an alternate screw or bone graft.

If you or a loved one has been seriously injured after surgical implantation of a Calaxo bone screw, please contact us immediately for a free consultation.

About The Mulligan Law Firm
The Mulligan Law Firm is a national law firm located in Dallas, Texas, providing information and resources for injured individuals and their families in all 50 states. The firm has successfully resolved over $600,000,000 in claims for its clients since 1995.

The Mulligan Law Firm is currently investigating injury claims involving the Calaxo surgical screw. Anyone who has been injured or experienced complications after being implanted with this device should consult with a lawyer immediately - Contact Eric Gruenwald, Attorney/Lawyer at (866) 529-0001, Ext. 245.

The Mulligan Firm has experienced lawyers ready to help.

All cases are taken on a contingency-fee basis, which means the prospective client does not pay for our services unless an award or compensation is received.

###

OPTIONS
Printer Friendly Printer Friendly Version
Adobe PDF Download PDF Version
Adobe PDF Download Reader Version
Email Email this story to a colleague
CONTACT INFORMATION
Eric Gruenwald
The Mulligan Law Firm
866 529 0001 x245
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.